← All sectors / The AI transformation
072 · Medical imaging AI
Reading the scan first
Curve position
Binding constraint
Reimbursement codes, which determine whether a cleared algorithm ever gets used.
Why this sector sits at Liftoff
The FDA has cleared 1,000+ AI/ML medical devices with radiology at ~75% of the total, Tempus reported $1.27B in 2025 revenue (83% YoY growth), a foundation model-powered multi-condition CT triage tool received FDA clearance in January 2026, and enterprise deployment at hospitals is compounding rapidly.
Reviewed on a two month cycle. The position moves only when a dated, verifiable change in the binding constraint justifies it.
Heatmap / How this sector's stocks are moving
| Stock | Price | 1 Day | 1 Week | 1 Month | Year to date |
|---|---|---|---|---|---|
| $GEHC | $85.81 | +6.38% | +13.18% | +32.48% | +4.62% |
| $PHG | $31.06 | +9.14% | +14.91% | +28.61% | +14.70% |
| $TEM | $75.61 | −2.81% | −1.31% | +5.04% | +28.04% |
| $SIEGY | $151.52 | −2.92% | −1.25% | −0.40% | +8.27% |
| Sector average | +2.45% | +6.38% | +16.43% | +13.91% |
Prices as of November 5, 2026. The sector's move is the equal-weighted average of these listed companies, a market proxy for context, not recommendations. See it on the full heatmap →
Sentiment / The mood in this sector's stocks
Since 2018, Medical imaging AI has been in Euphoria and rising 20 separate times. After those, its stocks beat their usual three months 12 times (60%), by a median of +0.7 points.
Confidence: low, a split like this is common by chance, so no edge is called.
Imaging volume grows faster than the radiologist workforce every year. Algorithms that triage urgent findings, measure structures, and flag abnormalities do not replace the radiologist but decide what reaches them first.
Historically computer aided detection over promised and under delivered, producing so many false positives that radiologists disabled it. That failure shaped professional skepticism that current vendors still have to overcome.
The structural driver is workforce arithmetic. Scan volumes rise with an aging population while training pipelines are fixed, so throughput per radiologist has to increase or backlogs grow indefinitely.
The technology layer spans detection and triage algorithms for specific findings, quantification tools that measure rather than classify, workflow integration into the reading environment, and the platforms that manage a portfolio of algorithms.
Adoption economics hinge entirely on reimbursement. Where a code exists for an algorithm, hospitals deploy it; where it does not, cleared products sit unused regardless of clinical performance.
The beneficiaries include imaging AI vendors with clearances and reimbursement, the imaging equipment manufacturers embedding algorithms in scanners, platform companies aggregating third party algorithms, and teleradiology providers.
The value chain runs from scanner through image storage and workflow to the reading radiologist. Workflow integration is the moat, since an algorithm outside the reading environment does not get used.
The overlooked layer includes imaging workflow and archive vendors, teleradiology services scaling with AI leverage, and small cap algorithm developers in specific modalities that larger platforms acquire.
Competitive dynamics favor platforms and scanner manufacturers with distribution, while point solutions compete for the same limited attention in the reading room.
Risks: reimbursement decisions gate the entire market, liability for missed findings is unsettled, clinical validation requirements are demanding, and hospital IT integration is slow and expensive.
What to watch: new reimbursement codes for imaging algorithms, clearance volumes, deployment counts at named health systems, and scanner manufacturers embedding AI as standard.
Coverage / Daily Disruptor issues in this sector
